Jiangsu Hengrui Medicine
600276.SS
#488
Rank
$40.79 B
Marketcap
$6.40
Share price
0.65%
Change (1 day)
1.59%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2023 : $12.54 M

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is $12.54 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2001 to 2023)

Total debt by year

Year Total debt Change
2022-12-31$0.19 B728.78%
2021-12-31$23.78 M
2015-12-31$1.54 M-4.18%
2014-12-31$1.61 M-51.13%
2013-12-31$3.3 M106.05%
2012-12-31$1.6 M-49.6%
2011-12-31$3.18 M5.21%
2010-12-31$3.02 M106.6%
2009-12-31$1.46 M
2007-12-31$8.22 M33.77%
2006-12-31$6.14 M3.36%
2005-12-31$5.94 M-50.32%
2004-12-31$11.97 M-73.95%
2003-12-31$45.97 M48.36%
2002-12-31$30.98 M1.82%
2001-12-31$30.43 M